Vaccination of allogeneic hematopoietic stem cell transplant recipients-what should be considered?

Affiliations

¹ Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, D- 07740, Jena, Germany. inken.hilgendorf@med.uni-jena.de.
² Division of Hematology, Medical University of Graz, Graz, Austria.
³ Internal Medicine, Department of Hematology, University Hospital of Basel, Basel, Switzerland.
⁴ St. Anna Children's Hospital, Medical University Vienna, Vienna, Austria.
⁵ Department of Internal Medicine III, Haematology and Oncology, University Medical Center of Regensburg, Regensburg, Germany.

Comment

Inken Hilgendorf et al. Ann Hematol. 2017 Apr.

. 2017 Apr;96(4):701-702.

doi: 10.1007/s00277-017-2922-0. Epub 2017 Jan 17.

¹ Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, D- 07740, Jena, Germany. inken.hilgendorf@med.uni-jena.de.
² Division of Hematology, Medical University of Graz, Graz, Austria.
³ Internal Medicine, Department of Hematology, University Hospital of Basel, Basel, Switzerland.
⁴ St. Anna Children's Hospital, Medical University Vienna, Vienna, Austria.
⁵ Department of Internal Medicine III, Haematology and Oncology, University Medical Center of Regensburg, Regensburg, Germany.

No abstract available

Comment on

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.
Ullmann AJ, Schmidt-Hieber M, Bertz H, Heinz WJ, Kiehl M, Krüger W, Mousset S, Neuburger S, Neumann S, Penack O, Silling G, Vehreschild JJ, Einsele H, Maschmeyer G; Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology (AGIHO/DGHO) and the DAG-KBT (German Working Group for Blood and Marrow Transplantation). Ullmann AJ, et al. Ann Hematol. 2016 Sep;95(9):1435-55. doi: 10.1007/s00277-016-2711-1. Epub 2016 Jun 24. Ann Hematol. 2016. PMID: 27339055 Free PMC article.